Sundrug Co.,Ltd.
SDGCFOTCHealthcare● Active
$30.97
+$2.79(+9.90%)
Market Cap$3.6B
P/E Ratio—
52W High$30.97
52W Low$28.18
Sundrug Co.,Ltd. (SDGCF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SDGCF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $847.82B | $801.81B | $751.78B | $690.46B | $648.73B |
| Cost of Revenue | $649.16B | $597.72B | $562.46B | $3.90B | $4.04B |
| Gross Profit | $198.65B | $204.09B | $189.32B | $1.29B | $1.29B |
| Gross Margin %(computed) | 23.43% | 25.45% | 25.18% | 0.19% | 0.20% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $151.53B | $159.59B | $148.32B | $1.01B | $1.01B |
| Operating Income | $47.13B | $44.50B | $41.00B | $37.45B | $34.05B |
| Operating Margin %(computed) | 5.56% | 5.55% | 5.45% | 5.42% | 5.25% |
| Interest Income | $0.24B | $0.15B | $0.12B | $0.12B | $0.12B |
| Interest Expense | $0.39B | $0.16B | $0.03B | $0.04B | $0.01B |
| Income Before Tax | $46.09B | $43.57B | $41.26B | $37.71B | $34.67B |
| Income Tax Expense | $14.50B | $12.82B | $12.13B | $12.01B | $10.82B |
| Net Income | $31.59B | $30.75B | $29.13B | $25.70B | $23.85B |
| Net Margin %(computed) | 3.73% | 3.84% | 3.87% | 3.72% | 3.68% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $270.03 | $262.91 | $249.07 | $219.83 | $204.02 |
| Wtd Avg Shares | 0.12B | 0.12B | 0.12B | 0.12B | 0.12B |
| EBITDA | $66.01B | $61.02B | $56.12B | $49.81B | $44.89B |
| EBITDA Margin %(computed) | 7.79% | 7.61% | 7.47% | 7.21% | 6.92% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · JPY · B
Explore more Sundrug Co.,Ltd. data
About Sundrug Co.,Ltd. (SDGCF) Income Statement
Sundrug Co.,Ltd. (SDGCF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2026, SDGCF reported revenue of $847.82B, gross profit of $198.65B (gross margin 23.43%), and net income of $31.59B — a net profit margin of 3.73%.
Frequently asked questions
SDGCF · 4 questionsSundrug Co.,Ltd. (SDGCF) reported revenue of $847.82B for 2026, up 5.7% year-over-year.
SDGCF revenueSDGCF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09